Home/Rare Diseases/Takayasu Arteritis

Autoimmune & Inflammatory

Takayasu Arteritis

Also called Takayasu Disease, Aortoarteritis, Pulseless Disease

Takayasu Arteritis is a chronic, granulomatous inflammatory disease of large elastic arteries, particularly the aorta and its proximal branches. The pathophysiology involves T cell-mediated inflammatory infiltration of the vessel wall, leading to intimal thickening, medial hypertrophy, fibrosis, and vascular remodeling.

View active trialsMatch me to a trial

About Takayasu Arteritis

Takayasu Arteritis is a chronic, granulomatous inflammatory disease of large elastic arteries, particularly the aorta and its proximal branches. The pathophysiology involves T cell-mediated inflammatory infiltration of the vessel wall, leading to intimal thickening, medial hypertrophy, fibrosis, and vascular remodeling. The disease progresses through an active inflammatory phase followed by a fibrotic phase characterized by stenosis, dilation, and aneurysm formation. Vessel involvement is heterogeneous, with some patients having primarily aortic and proximal branch involvement while others develop more distal disease. Acute phase symptoms include constitutional symptoms (fever, malaise, fatigue), elevated inflammatory markers (ESR, CRP), and progressive vascular involvement. The chronic phase is characterized by vascular narrowing (stenosis) and dilation (aneurysms) leading to organ ischemia and hemodynamic complications. Renal artery involvement causes hypertension. Coronary artery involvement increases myocardial infarction risk. Aortic root involvement leads to aortic regurgitation and heart failure. Neurologic complications can result from carotid or vertebral artery involvement. Diagnosis requires integration of clinical, imaging (angiography, high-resolution ultrasound, CT/MRI), and sometimes histologic findings.

Common Symptoms

  • Fatigue, malaise, and fever (in active phases)
  • Limb claudication (pain with activity) from arterial narrowing
  • Headaches and visual disturbances from carotid involvement
  • Chest or back pain from aortic involvement
  • Hypertension from renal artery involvement
  • Aortic regurgitation causing heart failure symptoms

Who It Affects

Takayasu Arteritis predominantly affects young women aged 10-40 years, with 80% of cases occurring in females. The disease most commonly affects populations from Asia (particularly East and Southeast Asia), Africa, India, and the Middle East. It is much less common in Caucasian populations and North America. Disease can manifest in childhood or adolescence. Pregnancy-related disease activity occurs in some women.

Getting Involved in Clinical Trials

Clinical trials for Takayasu Arteritis focus on immunosuppressive and biologic therapies, particularly TNF inhibitors and newer targeted therapies. Trials investigate optimal induction and maintenance therapy, combination approaches, and strategies to prevent relapses and organ complications. Trials examining mycophenolate mofetil, tocilizumab, and other biologics are ongoing. Management involves controlling inflammation, monitoring vascular complications, and managing hemodynamic sequelae. Patients should consult with a rheumatologist experienced in vasculitis.

Trusted Sources

Active Clinical Trials for Takayasu Arteritis

Finding trials for Takayasu Arteritis...

Related Autoimmune & Inflammatory Conditions

Autoimmune & Inflammatory

Giant Cell Arteritis

Giant Cell Arteritis is a rare inflammatory disease of large and medium-sized arteries, primarily affecting people over ...

Autoimmune & Inflammatory

Granulomatosis with Polyangiitis

Granulomatosis with Polyangiitis is a rare autoimmune disease causing inflammation of small and medium blood vessels in ...

Autoimmune & Inflammatory

Behçet Disease

Behçet Disease is a rare, chronic, recurrent vasculitis causing painful oral and genital ulcers, eye inflammation, and s...